Expected earnings - Aptose Biosciences Inc.
Source: Canadian Earnings Reports
Aptose Biosciences Inc. (APS:CA) is expected to report for Q2 2025
Aptose Biosciences Inc.
NASDAQ: APS:CC
APS:CC Trading
-5.1% G/L:
$0.93 Last:
17,948 Volume:
$0.98 Open:
APS:CC Latest News
February 24, 2026 07:00:00 am
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
December 19, 2025 05:05:31 pm
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
December 06, 2025 08:00:00 am
Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
November 19, 2025 01:22:25 am
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
